-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WpX69fRnRIbe1mA7YfLPHWBZQumqeiv5nGpJrf23GwRMupUl8OjCTHci4xmaO9Dg jNlARbUQazslzLkeYdg0lA== 0000927016-02-000611.txt : 20020414 0000927016-02-000611.hdr.sgml : 20020414 ACCESSION NUMBER: 0000927016-02-000611 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020208 GROUP MEMBERS: ATLAS INVESTERINGSGROEP NV GROUP MEMBERS: ATLAS VENTURE ASSOCIATES II LP GROUP MEMBERS: ATLAS VENTURE EUROPE FUND BV SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DECODE GENETICS INC CENTRAL INDEX KEY: 0001022974 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043326704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-59361 FILM NUMBER: 02531608 BUSINESS ADDRESS: STREET 1: LYNGHALS 1 STREET 2: REYJKAVIK CITY: ICELAND STATE: K6 ZIP: 00000 BUSINESS PHONE: 0113545701900 MAIL ADDRESS: STREET 1: LYNGHALSI 1 STREET 2: REYKJAVIK CITY: ICELAND STATE: K6 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ATLAS VENTURE FUND II L P CENTRAL INDEX KEY: 0001030571 IRS NUMBER: 043226975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6178599290 MAIL ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 SC 13G 1 dsc13g.txt SCHEDULE 13G ------------------------------ / OMB APPROVAL / -----------------------------/ / OMB Number: 3235-0145 / / Expires: October 31, 2002 / / Estimated average burden / / hours per response...14.90 / ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___________)* deCODE genetics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 243586104 -------------------------------------- (CUSIP Number) - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 243586104 Page 2 of 13 - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Fund II, L.P. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware Limited Partnership - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 0 shares SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 2,335,082 shares ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 0 shares PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH: 8 2,335,082 shares - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 2,335,082 shares - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 5.2% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 PN - ------------------------------------------------------------------------------ CUSIP NO. 243586104 Page 3 of 13 - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Associates II, L.P. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware Limited Partnership - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 0 shares SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 2,335,082 shares ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 0 shares PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH: 8 2,335,082 shares - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 2,335,082 shares - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 5.2% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 PN - ------------------------------------------------------------------------------ CUSIP NO. 243586104 Page 4 of 13 - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas Venture Europe Fund B.V. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 The Netherlands - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 0 shares SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 2,335,082 shares ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 0 shares PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH: 8 2,335,082 shares - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 2,335,082 shares - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 5.2% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 CO - ------------------------------------------------------------------------------ CUSIP NO.243586104 Page 5 of 13 --------- - ------------------------------------------------------------------------------ NAMES OF REPORTING PERSONS 1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Atlas InvesteringGroep N.V. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 The Netherlands - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 0 shares SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 OWNED BY 2,335,082 shares ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 0 shares PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH: 8 2,335,082 shares - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 2,335,082 shares - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10 (SEE INSTRUCTIONS) [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 5.2% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 12 CO - ------------------------------------------------------------------------------ Schedule 13G ------------ Item 1(a). Name of Issuer: deCODE genetics, Inc. -------------- Item 1(b). Address of Issuer's Principal Executive Offices: ----------------------------------------------- Lynghals 1, Reykjavik, Iceland. Item 2(a). Names of Persons Filing: Atlas Venture Fund II, L.P., Atlas ----------------------- Venture Associates II, L.P., Atlas Venture Europe Fund B.V. and Atlas InvesteringsGroep N.V. Atlas Venture Associates II, L.P. is the sole general partner of Atlas Venture Fund II, L.P. Atlas InvesteringsGroep N.V. owns 95% of the shares of Atlas Venture Europe Fund B.V. Item 2(b). Address of Principal Business Office or, if None, Residence: ----------------------------------------------------------- The address of the principal business office of Atlas Venture Fund II, L.P. and Atlas Venture Associates II, L.P. is Atlas Venture, 222 Berkeley Street, Boston, Massachusetts 02116. The address of the principal business office of Atlas Venture Europe Fund B.V. and Atlas InvesteringsGroep N.V. is Atlas InvesteringsGroep N.V., Leevwenveldesweg 16, 1382 LX Weesp, The Netherlands. Item 2(c). Citizenship: Atlas Venture Fund II, L.P. and Atlas Venture ----------- Associates II, L.P. are each a limited partnership organized under the laws of the State of Delaware. Atlas Venture Europe Fund B.V. and Atlas InvesteringsGroep N.V. are each a corporation organized under the laws of The Netherlands. Item 2(d). Title of Class of Securities: Common Stock, $.001 par value. ---------------------------- Item 2(e). CUSIP Number: 243586104. ------------ Item 3. If this statement is filed pursuant to Rules 13d-1(b), or --------------------------------------------------------- 13d-2(b) or (c), check whether the person filing is a: ----------------------------------------------------- Not Applicable. Item 4. Ownership. --------- (a) Amount Beneficially Owned: Each of Atlas Venture Fund II, L.P., Atlas Venture Associates II, L.P., Atlas Venture Europe Fund B.V. and Atlas InvesteringsGroep N.V. (individually an "Entity" and collectively the "Entities") may be deemed to own beneficially 2,335,082 shares of Common Stock as of December 31, 2001 (including 2,085,082 shares and warrants exercisable for 250,000 shares). As of December 31, 2001, Atlas Venture Fund II, L.P. is the record owner of 1,167,541 shares (including a warrant exercisable for 125,000 shares) of Common Stock and Atlas Venture Europe Fund B.V. is the record owner of Page 6 of 13 1,167,541 shares (including a warrant exercisable for 125,000 shares) of Common Stock (referred to as the "Record Shares"). By virtue of the affiliate relationships among the Entities, each Entity may be deemed to own beneficially all of the Record Shares. Hence, each Entity may be deemed to own beneficially 2,335,082 shares of Common Stock. (b) Percent of Class: Atlas Venture Fund II, L.P. 5.2% Atlas Venture Associates II, L.P. 5.2% Atlas Venture Europe Fund B.V. 5.2% Atlas InvesteringsGroep N.V. 5.2% The foregoing percentages are calculated based on the 45,173,463 shares of Common Stock reported to be outstanding in a Quarterly Report on Form 10-Q for deCODE genetics, Inc. for the Quarter Ended September 30, 2001, as adjusted pursuant to Rule 13d-3(d)(1). (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 shares as to each reporting person. (ii) shared power to vote or to direct the vote: Atlas Venture Fund II, L.P. 2,335,082 shares Atlas Venture Associates II, L.P. 2,335,082 shares Atlas Venture Europe Fund B.V. 2,335,082 shares Atlas InvesteringsGroep N.V. 2,335,082 shares (iii) sole power to dispose or to direct the disposition of: 0 shares as to each reporting person. (iv) shared power to dispose or to direct the disposition of: Atlas Venture Fund II, L.P. 2,335,082 shares Atlas Venture Associates II, L.P. 2,335,082 shares Atlas Venture Europe Fund B.V. 2,335,082 shares Atlas InvesteringsGroep N.V. 2,335,082 shares Each of the reporting persons expressly disclaims beneficial ownership of any shares of Common Stock of deCODE genetics, Inc., except in the case of (i) Atlas Venture Fund II, L.P. for the 1,167,541 shares which it holds of record; and (ii) Atlas Venture Europe Fund B.V. for the 1,167,541 shares which it holds of record. Item 5. Ownership of Five Percent or Less of a Class. -------------------------------------------- Not Applicable. Page 7 of 13 Item 6. Ownership of More than Five Percent on Behalf of Another Person. --------------------------------------------------------------- Not Applicable. Item 7. Identification and Classification of the Subsidiary Which --------------------------------------------------------- Acquired the Security Being Reported on by the Parent Holding ------------------------------------------------------------- Company. ------- Not Applicable. Item 8. Identification and Classification of Members of the Group. --------------------------------------------------------- Not Applicable. The reporting persons expressly disclaim membership in a "group" as defined in Rule 13d-1(b)(1)(ii)(J). Item 9. Notice of Dissolution of Group. ------------------------------ Not Applicable. Item 10. Certifications. -------------- Not Applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b) or Rule 13d-1(c). Page 8 of 13 Signatures ---------- After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. We also hereby agree to file this statement jointly pursuant to the Agreement listed on Exhibit 1 hereto. --------- Dated: February 8, 2002 ATLAS VENTURE FUND II, L.P. ATLAS VENTURE EUROPE FUND B.V. By: Atlas Venture Associates II, L.P. By: Atlas InvesteringsGroep N.V. By: * By: * -------------------------------- ------------------------- Christopher J. Spray, Hans Bosman, General Partner Managing Director ATLAS VENTURE ASSOCIATES II, L.P. ATLAS INVESTERINGSGROEP N.V. By: * By: * ---------------------------------------- --------------------------- Christopher J. Spray, Hans Bosman, General Partner Managing Director * The undersigned attorney-in-fact, by signing her name below, does hereby sign this statement on behalf of the above indicated filers pursuant to Powers of Attorney filed hereto as Exhibit 2. ---------- /s/Jeanne Larkin Henry -------------------------- Jeanne Larkin Henry Attorney-in-fact Page 9 of 13 Exhibit 1 --------- AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of deCODE genetics, Inc. This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 8th day of February, 2002. ATLAS VENTURE FUND II, L.P. ATLAS VENTURE EUROPE FUND B.V. By: Atlas Venture Associates II, L.P. By: Atlas InvesteringsGroep N.V. By: * By: * ------------------------------- ----------------- Christopher J. Spray, Hans Bosman, General Partner Managing Director ATLAS VENTURE ASSOCIATES II, L.P. ATLAS INVESTERINGSGROEP N.V. By: * By: * -------------------------------------- ------------------------- Christopher J. Spray, Hans Bosman, General Partner Managing Director * The undersigned attorney-in-fact, by signing her name below, does hereby sign this statement on behalf of the above indicated filers pursuant to Powers of Attorney filed hereto as Exhibit 2. --------- /s/Jeanne Larkin Henry --------------------------- Jeanne Larkin Henry Attorney-in-fact Page 10 of 13 Exhibit 2 --------- POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints each and any of Christopher J. Spray and Jeanne Larkin Henry his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to sign any and all instruments, certificates and documents required to be executed on behalf of himself individually or on behalf of each or any of Atlas Venture Fund, L.P., Atlas Venture Associates, L.P., Atlas Venture Partners III, B.V., Atlas Venture Fund II, L.P., Atlas Venture Associates II, L.P., Atlas Venture Europe Fund B.V., Atlas InvesteringsGroep N.V., and Atlas Venture Beheer II B.V. pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the National Association of Securities Dealers, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he might or could do in person thereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. [REMAINDER OF PAGE LEFT BLANK INTENTIONALLY] [SIGNATURE PAGE FOLLOWS IMMEDIATELY] Page 11 of 13 IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 31st day of January, 1997. /s/ Christopher J. Spray ------------------------------------ Christopher J. Spray Commonwealth of Massachusetts) ) ss: County of Suffolk ) On this 31st day of January, 1997, before me personally came Christopher J. Spray, known to me to be the person described and who executed the foregoing instrument that he acknowledged that he executed the same. [Notary Seal] /s/ Elizabeth A. LeBlanc ------------------------------------ Notary Public My commission expires: July 3, 1998 IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 7th day of February, 2000. /s/ Hans Bosman ---------------------------------------- Hans Bosman Commonwealth of Massachusetts) ) ss: County of Suffolk ) On this 7th day of February, 2000, before me personally came Hans Bosman, known to me to be the person described and who executed the foregoing instrument that he acknowledged that he executed the same. [Notary Seal] /s/ Ann M. Grummitt ---------------------------------------- Notary Public My commission expires: November 6, 2003 Page 13 of 13 -----END PRIVACY-ENHANCED MESSAGE-----